A China-led team of scientists has developed an ultra-flexible brain implant electrode that could address one of the biggest challenges facing brain-computer interface (BCI) technology: the mismatch between rigid electrodes and soft brain tissue.
Traditional implants often suffer from signal degradation over time because the brain’s natural movement can cause inflammation, scarring and damage around hard electrodes. The newly developed device is designed to match the softness of brain tissue, potentially improving long-term performance and biocompatibility.
Record Conductivity and Signal Quality
At the heart of the breakthrough is a new material known as an interfacial percolation conductive hydrogel, which achieved a record electrical conductivity of 2,512 S/cm. According to the researchers, this allows for exceptionally clear transmission of neural signals while maintaining flexibility.
High-Density Neural Recording
The implant features a 128-channel electrode array that is only 9 microns thick—thinner than a human hair. It also achieves a channel density of 853 channels per square centimetre, more than ten times higher than previous hydrogel-based electrode designs.
This high-density configuration could enable more detailed monitoring of brain activity while minimising the device’s physical footprint.
Built to Withstand Brain Movement
To test durability, researchers subjected the electrode to 1,000 stretching cycles designed to simulate the movement and deformation experienced inside the brain. Performance declined by less than 4 per cent, demonstrating strong mechanical stability.
Stable Performance for More Than a Year
In long-term testing, the team successfully recorded stable neural signals for 550 days. Researchers reported no visible signs of inflammation, scarring or tissue damage around the implant, suggesting a high level of compatibility with brain tissue.
The development could help advance future brain-computer interfaces by improving the longevity and reliability of implanted neural devices, a key requirement for clinical and commercial applications.
